Shao M - Search Results

1

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan ML, Allayee H, Lusis AJ, Hazen SL. Bhattacharyya T, et al. Among authors: shao m. JAMA. 2008 Mar 19;299(11):1265-76. doi: 10.1001/jama.299.11.1265. JAMA. 2008. PMID: 18349088 Free PMC article.

2

The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.

Mak KH, Bhatt DL, Shao M, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Montalescot G, Steg PG, Steinhubl SR, Fox KA, Topol EJ. Mak KH, et al. Among authors: shao m. Eur Heart J. 2009 Apr;30(7):857-65. doi: 10.1093/eurheartj/ehp037. Epub 2009 Feb 20. Eur Heart J. 2009. PMID: 19233855 Free article. Clinical Trial.

3

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.

Mak KH, Bhatt DL, Shao M, Hankey GJ, Easton JD, Fox KA, Topol EJ. Mak KH, et al. Among authors: shao m. Am Heart J. 2009 Apr;157(4):658-65. doi: 10.1016/j.ahj.2008.08.031. Epub 2008 Nov 6. Am Heart J. 2009. PMID: 19332192 Clinical Trial.

4

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.

Berger JS, Bhatt DL, Steinhubl SR, Shao M, Steg PG, Montalescot G, Hacke W, Fox KA, Lincoff AM, Topol EJ, Berger PB; CHARISMA Investigators. Berger JS, et al. Among authors: shao m. Circulation. 2009 Dec 8;120(23):2337-44. doi: 10.1161/CIRCULATIONAHA.109.866533. Epub 2009 Nov 23. Circulation. 2009. PMID: 19933933 Free PMC article. Clinical Trial.

5

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, Brennan DM, Hacke W, Montalescot G, Steinhubl SR, Topol EJ; CHARISMA Investigators. Berger PB, et al. Among authors: shao m. Circulation. 2010 Jun 15;121(23):2575-83. doi: 10.1161/CIRCULATIONAHA.109.895342. Epub 2010 Jun 1. Circulation. 2010. PMID: 20516378 Free article. Clinical Trial.

6

Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.

Bayturan O, Kapadia S, Nicholls SJ, Tuzcu EM, Shao M, Uno K, Shreevatsa A, Lavoie AJ, Wolski K, Schoenhagen P, Nissen SE. Bayturan O, et al. Among authors: shao m. J Am Coll Cardiol. 2010 Jun 15;55(24):2736-42. doi: 10.1016/j.jacc.2010.01.050. J Am Coll Cardiol. 2010. PMID: 20538166 Free article. Clinical Trial.

7

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

Berger JS, Bhatt DL, Steg PG, Steinhubl SR, Montalescot G, Shao M, Hacke W, Fox KA, Berger PB, Topol EJ, Lincoff AM. Berger JS, et al. Among authors: shao m. Am Heart J. 2011 Jul;162(1):98-105.e1. doi: 10.1016/j.ahj.2011.04.015. Am Heart J. 2011. PMID: 21742095 Clinical Trial.

8

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE. Nicholls SJ, et al. Among authors: shao m. JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649. JAMA. 2011. PMID: 22089718 Clinical Trial.

9

Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.

Kataoka Y, Shao M, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ. Kataoka Y, et al. Among authors: shao m. Eur J Prev Cardiol. 2013 Apr;20(2):209-17. doi: 10.1177/2047487312437931. Epub 2012 Jan 31. Eur J Prev Cardiol. 2013. PMID: 22345692

10

Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.

Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. Puri R, et al. Among authors: shao m. Eur Heart J. 2013 Nov;34(41):3182-90. doi: 10.1093/eurheartj/eht260. Epub 2013 Jul 25. Eur Heart J. 2013. PMID: 23886915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,018 results

Search Page

Filters